Screener
CytomX Therapeutics CTMX Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from CytomX Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: CytomX Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337950
FAQ
- What is CytomX Therapeutics's price / sales?
- CytomX Therapeutics (CTMX) reported price / sales of 44.6× in Q2 2026.
- How has CytomX Therapeutics's price / sales changed year-over-year?
- CytomX Therapeutics's price / sales increased by 1766.8% year-over-year, from 2.4× to 44.6×.
- What is the long-term trend for CytomX Therapeutics's price / sales?
- Over 5 years (2020 to 2025), CytomX Therapeutics's price / sales has grown at a 8.7% compound annual growth rate (CAGR), from 6.2× to 9.5×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about CytomX Therapeutics's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude